The Quality Payment Program (QPP) from CMS, including the Medicare Access and CHIP Reauthorization Act (MACRA), represents a shift toward focusing on quality measures, but there are resources available to help clinicians adjust to these changes, explained William Borden, MD, FACC, FAHA, associate professor of medicine and director of healthcare delivery transformation at the George Washington University.
The Quality Payment Program (QPP) from CMS, including the Medicare Access and CHIP Reauthorization Act (MACRA), represents a shift toward focusing on quality measures, but there are resources available to help clinicians adjust to these changes, explained William Borden, MD, FACC, FAHA, associate professor of medicine and director of healthcare delivery transformation at the George Washington University.
Transcript (slightly modified)
How will MACRA change the way you practice as a cardiologist?
It’s interesting, MACRA and the QPP has been really focused on quality measures, which is something that cardiology has been focused on for many years. So I think it’s an increasing work in that quality space, but it’s beginning to look more broadly than just the cardiovascular team. So it’s thinking about how we interact and partner with primary care, with other specialists, with nurses, pharmacists, social workers, and thinking about the care of our patients.
It’s really about looking towards the future, because MACRA’s really the beginning, and the incentive payments are going to grow over time with MACRA, as well as more movement with commercial payers into this space. A lot of what I see here is that it’s building the infrastructure, the experience to be successful in the future.
What advice would you give to other cardiologists on how to succeed under MACRA?
There are probably 3 parts. One is just trying to understand the program, so it seems rather complex but there are resources out there available, so for instance here, at the American College of Cardiology [ACC]; MACRA Hub is another great resource; Medicare and their QPP website is a great resource. And just trying to look at the different components, look at what capabilities and experience that you and your practice have already, and then where can you go from that.
The second is looking at what things are available to you through your EHR [electronic health record] vendor, or again through ACC, tools around reporting, around quality improvement. And then the third is to stay focused on the patients. So, there’s a lot that can be done in these programs to be successful, and you can end up focusing a lot on those specifics. I think if you focus on trying to do the right thing for patients and creating a culture of quality, and also meeting the specifics of the programs, I think that is going to be the most patient-centric approach to success in the future.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More